Atreca, Inc.

ATRECA

Research, design and development of diagnostics for predicting the response of patients to therapeutics; research, design and development of biologics; research, design and development of combinations of such diagnostics and biologics;

ATRECA

Diagnostic preparations and diagnostic kits comprised of buffers and reagents for medical use, for predicting the response of patients to therapeutics; biologics for medical use, namely, biological preparation for the treatment of infectious disease; biologics for medical use, namely, biological preparation for the treatment of cancer; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologics for medical use, namely, biological preparation for the treatment of animal health; biologics, namely, biological tissue for medical diagnosis; biologics, namely, antibodies for medical diagnosis; biologics, namely, vaccines for medical diagnosis, research and scientific diagnosis; combinations of biologics for medical use, namely, biological preparation for the treatment of infectious disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cancer; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; combinations of biologics for medical use, namely, biological preparation for the treatment of animal health; combinations of biologics, namely, biological tissue, antibodies, and vaccines, for medical diagnosis;Color is not claimed as a feature of the mark.;Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medical laboratory, or research use, for predicting the response of patients to therapeutics; biological tissue for research and scientific diagnosis use; antibodies for research and scientific diagnosis use; combinations of biological tissue for research and scientific diagnosis use; combinations of antibodies for research and scientific diagnosis use; kits containing buffers and chemical reagents for use in molecular biology research applications;

ATRECA

Diagnostic preparations and diagnostic kits comprised of buffers and reagents for medical use, for predicting the response of patients to therapeutics; biologics for medical use, namely, biological preparation for the treatment of infectious disease; biologics for medical use, namely, biological preparation for the treatment of cancer; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologics for medical use, namely, biological preparation for the treatment of animal diseases; biologics, namely, biological tissue cultures for medical diagnosis; biologics, namely, antibodies for medical diagnosis; biologics, namely, vaccines for medical diagnosis, research and scientific diagnosis; combinations of biologics for medical use, namely, biological preparation for the treatment of infectious disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cancer; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; combinations of biologics for medical use, namely, biological preparation for the treatment of animal diseases; combinations of biologics, namely, biological tissue cultures, antibodies, and vaccines, for medical diagnosis;Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medical laboratory, or research use; biological tissue cultures for research and scientific diagnosis use; antibodies reagents for research and scientific diagnosis use; combinations of biological tissue cultures for research and scientific diagnosis use; combinations of antibody reagents for research and scientific diagnosis use; kits containing buffers and chemical reagents for use in molecular biology research;

ATRECA

Biologics for medical use, namely, biological preparation for the treatment of cancer;

ATRECA

Biologics for medical use, namely, biological preparations for the treatment or prophylaxis of cancer; biologics for medical use, namely, biological preparations for the treatment or prophylaxis of infectious diseases; pharmaceutical preparations, biologics and antibodies for the treatment of oncological, infectious disease, and immune system related diseases, disorders and conditions; diagnostic agents, preparations and substances for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations, biologics and antibodies for medical purposes, namely, for detecting the presence of malignant, inflammatory, infectious and autoimmune diseases, disorders and conditions in humans;Diagnostic preparations for clinical use and scientific research; biological tissue cultures for clinical use and scientific research; antibodies for clinical use and scientific research; combinations of biological tissue cultures for clinical use and scientific research; and combinations of antibodies for clinical use and scientific research;Biological and pharmaceutical research and development; research, design and development of diagnostics for predicting the response of patients to therapeutics; research, design and development of biologics; research, design and development of combinations of such diagnostics and biologics; molecular biology research for diagnostic preparations, biologics, combinations of diagnostic preparations and biologics, and diagnostic kits for scientific research use; scientific research in the field of cancer and infectious disease treatment and diagnosis; providing laboratory research services in the field of cancer biology and infectious disease biology; testing, inspection, research and development of pharmaceutical preparations for cancer and infectious diseases; providing laboratory research services in the field of cancer biology and infectious diseases; research and development services in the field of antibodies; providing medical and scientific research information in the fields of cancer research, infectious disease research and disease classification; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;

IMMUNE REPERTOIRE CAPTURE

IMMUNE;Molecular biology research for diagnostic preparations, biologics, combinations of diagnostic preparations and biologics [, and diagnostic kits ] for scientific research use as related to immunotherapies and antibody- [ and T cell receptor- ] based disease treatments;

IRC

Research, design and development of diagnostics for predicting or monitoring the response of patients to therapeutics; research, design and development of biologics for predicting or monitoring the response of patients to therapeutics; research, design and development of diagnostics for diseases in humans, namely, infectious diseases, cancer, and respiratory diseases; research, design and development of biologics for the treatment of human diseases, namely, infectious diseases, cancer, and respiratory diseases;

NANOEXPRESS

NANO EXPRESS;Research, design and development of diagnostics for predicting the response of patients to therapeutics; research, design and development of biologics; research, design and development of combinations of such diagnostics and biologics; research, design and development of kits for use in particular molecular biology applications;